Bangor Savings Bank Vertex Pharmaceuticals Inc Transaction History

Bangor Savings Bank

$1.06 Billion
Q3 2024

A detailed history of Bangor Savings Bank transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Bangor Savings Bank holds 5,724 shares of VRTX stock, worth $2.27 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares

5,724

Previous 6,168 7.2%

Holding current value

$2.27 Million

Previous $2.89 Million 7.92%

% of portfolio

0.25%

Previous 0.29%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 07, 2024	SELL	$460.0 - $505.78 $204,240 - $224,566	-444 Reduced 7.2%	5,724 $2.66 Million
Q2 2024 Jul 15, 2024	SELL	$392.81 - $485.53 $57,350 - $70,887	-146 Reduced 2.31%	6,168 $2.89 Million
Q1 2024 Apr 11, 2024	SELL	$407.69 - $446.08 $165,929 - $181,554	-407 Reduced 6.06%	6,314 $2.64 Million
Q4 2023 Jan 16, 2024	SELL	$343.0 - $410.68 $33,957 - $40,657	-99 Reduced 1.45%	6,721 $2.73 Million
Q3 2023 Oct 24, 2023	SELL	$338.18 - $362.46 $57,828 - $61,980	-171 Reduced 2.45%	6,820 $2.37 Million
Q2 2023 Jul 07, 2023	BUY	$314.42 - $351.91 $15,406 - $17,243	49 Added 0.71%	6,991 $2.46 Million
Q1 2023 Apr 06, 2023	SELL	$283.23 - $323.1 $11,045 - $12,600	-39 Reduced 0.56%	6,942 $2.19 Million
Q4 2022 Jan 17, 2023	SELL	$285.76 - $321.48 $302,048 - $339,804	-1,057 Reduced 13.15%	6,981 $2.02 Million
Q3 2022 Oct 12, 2022	SELL	$273.83 - $305.53 $21,358 - $23,831	-78 Reduced 0.96%	8,038 $2.33 Million
Q2 2022 Aug 15, 2022	SELL	$234.96 - $292.55 $47,461 - $59,095	-202 Reduced 2.43%	8,116 $2.29 Million
Q1 2022 Apr 14, 2022	SELL	$221.42 - $260.97 $28,120 - $33,143	-127 Reduced 1.5%	8,318 $2.17 Million
Q4 2021 Jan 20, 2022	BUY	$177.01 - $223.45 $78,946 - $99,658	446 Added 5.58%	8,445 $1.86 Million
Q3 2021 Oct 15, 2021	BUY	$181.39 - $202.99 $173,953 - $194,667	959 Added 13.62%	7,999 $1.45 Million
Q2 2021 Jul 23, 2021	BUY	$187.49 - $221.1 $1.32 Million - $1.56 Million	7,040 New	7,040 $1.42 Million

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $102B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bangor Savings Bank, based on Form 13F filings with the SEC.

News

Stay updated on Bangor Savings Bank with notifications on news.

Account

Bangor Savings Bank Vertex Pharmaceuticals Inc Transaction History